PreAxia Health Care Payment Systems(PAXH)
$0.010.00 (0.00%)
PAXH
PreAxia Health Care Payment Systems financials statements
$0.01
At close:0.00 (0.00%)
PreAxia Health Care Payment Systems (PAXH) Ratios
13 Followers
PreAxia Health Care Payment Systems Ratios
PAXH's free cash flow for Q1 2027 was $-78.22K. For the 2027 fiscal year, PAXH's free cash flow was decreased by $-100.32K and operating cash flow was $22.10K. See a summary of the company’s cash flow.
| Ratios | May 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -1.18 | 0.04 | 0.00 | 0.01 | 0.02 |
| Operating Cash Flow Ratio | -0.13 | -0.02 | -0.01 | -0.02 | -0.03 |
| Short-Term Operating Cash Flow Coverage | -1.06 | -0.02 | -0.02 | -0.02 | -0.04 |
| Net Current Asset Value | $ -966.18K | $ -2.34M | $ -2.40M | $ -2.30M | $ -2.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | -220.69 | 122664.64 | 283107.33 | 6539.20 |
| Debt-to-Equity Ratio | -0.30 | -0.74 | -0.72 | -0.74 | -0.79 |
| Debt-to-Capital Ratio | -0.42 | -2.81 | -2.53 | -2.84 | -3.79 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.52 | 0.00 | -0.00 | -0.00 | -0.00 |
| Debt Service Coverage Ratio | -8.53 | 0.00 | 0.00 | 0.01 | 0.03 |
| Interest Coverage Ratio | -3045.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.92 | 1.52 | 1.51 | 0.85 |
| Interest Debt Per Share | 0.00 | 0.09 | 0.09 | 0.09 | 0.09 |
| Net Debt to EBITDA | -0.12 | 0.00 | 0.00 | 146.07 | 35.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | -49184.78% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 12903.53% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -49184.78% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -49184.78% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -49184.78% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -49184.78% |
| Net Income Per EBT | 100.00% | 65.46% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 117.00% | 53.91% | 100.00% | 100.00% | 100.00% |
| Return on Assets (ROA) | -199.01% | 686.10% | -710350.00% | -2600000.00% | -69884.17% |
| Return on Equity (ROE) | 302.81% | 2.29% | 4.15% | 6.79% | 8.46% |
| Return on Capital Employed (ROCE) | 258.81% | 6.48% | 4.15% | 6.79% | 8.46% |
| Return on Invested Capital (ROIC) | 368.40% | 24.45% | 14.65% | 26.08% | 40.51% |
| Return on Tangible Assets | -199.01% | 686.10% | -710350.00% | -2600000.00% | -69884.17% |
| Earnings Yield | -12.62% | -2.86% | -8.83% | -13.84% | -9.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 1.42 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Cash Conversion Cycle | -17151.34 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 17151.34 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -0.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -0.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.06 | -0.02 | -0.02 | -0.02 | -0.04 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -173.83 |
| Free Cash Flow Yield | -4.81% | -2.21% | -2.74% | -3.34% | -3.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.91 | -35.19 | -11.33 | -7.22 | -11.03 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 5425.46 |
| Price-to-Book (P/B) Ratio | -24.00 | -0.80 | -0.47 | -0.49 | -0.93 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -20.79 | -45.24 | -36.48 | -29.95 | -31.21 |
| Price-to-Operating Cash Flow Ratio | -75.98 | -45.24 | -36.48 | -29.95 | -31.21 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.76 | 0.31 | 0.55 | -1.14 |
| Enterprise Value Multiple | -9.55 | 0.00 | 0.00 | 242.96 | 77.71 |
| Enterprise Value | 9.32M | 3.61M | 2.84M | 2.83M | 3.69M |
| EV to EBITDA | -9.55 | 0.00 | 0.00 | 242.96 | 77.71 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 10027.07 |
| EV to Free Cash Flow | -21.05 | -86.83 | -92.08 | -75.11 | -57.68 |
| EV to Operating Cash Flow | -76.91 | -86.83 | -92.08 | -75.11 | -57.68 |
| Tangible Book Value Per Share | -0.01 | -0.12 | -0.12 | -0.12 | -0.11 |
| Shareholders’ Equity Per Share | -0.01 | -0.12 | -0.12 | -0.12 | -0.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.03 | -0.00 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 1.00 | 0.65 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.17 | 0.54 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 69.68 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 422.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.10 | 0.51 | 0.31 | 0.24 | 0.35 |
Currency in USD
